The DS-PSA Oxygen Generator segmentation by application reveals four primary demand clusters that collectively shape market size. Medical usage, encompassing hospital central plants, intensive‑care units, and home‑care ventilators, commands the largest share—approximately 55% of total revenue—driven by continuous, high‑purity oxygen requirements and regulatory mandates. Industrial applications, accounting for roughly 25%, include metal‑cutting oxy‑fuel systems, wastewater treatment aeration, and glass manufacturing, where bulk generation offsets the cost of cylinder logistics. Defense procurement contributes about 12%, focused on portable, ruggedized units for field hospitals and forward operating bases, where supply‑chain resilience is critical. Finally, Research laboratories and aerospace testing facilities represent an 8% niche, demanding precise oxygen concentrations for experimental protocols. Each segment’s growth trajectory is linked to sector‑specific capital investment cycles, and their proportional weight directly informs the aggregate market valuation for DS‑PSA oxygen generators.